P-523 Phase II trial of BBR3464, a novel, bifunctional platinum analog, as second line treatment of non-small cell lung cancer patients

Lung Cancer ◽

10.1016/s0169-5002(03)92490-1 ◽

2003 ◽

Vol 41 ◽

pp. S223 ◽

Cited By ~ 11

Author(s):

Giorgio Scagliotti ◽

Silvia Novello ◽

Lucio Crinò ◽

Filippo De Marinis ◽

Maurizio Tonato ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Second Line ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Phase II trial of second-line bendamustine chemotherapy in relapsed small cell lung cancer patients

Lung Cancer ◽

10.1016/j.lungcan.2006.09.029 ◽

2007 ◽

Vol 55 (1) ◽

pp. 109-113 ◽

Cited By ~ 38

Author(s):

Alexander Schmittel ◽

Maren Knödler ◽

Patricia Hortig ◽

Karsten Schulze ◽

Eckhard Thiel ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Second Line ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

A phase II trial evaluating the clinical and immunologic response of HLA-A2+ non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide

Lung Cancer ◽

10.1016/j.lungcan.2014.07.018 ◽

2014 ◽

Vol 86 (1) ◽

pp. 59-66 ◽

Cited By ~ 28

Author(s):

Athanasios Kotsakis ◽

Elisavet Papadimitraki ◽

Eleni Kyriaki Vetsika ◽

Despoina Aggouraki ◽

Eleftheria Kleio Dermitzaki ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Immunologic Response ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Cryptic Peptide

Download Full-text

Commentary on “Carboplatin–etoposide association in small cell lung cancer patients older than 70 years: a phase II trial”

Lung Cancer ◽

10.1016/s0169-5002(01)00289-6 ◽

2002 ◽

Vol 35 (1) ◽

pp. 9-10

Author(s):

Nevin Murray

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

19P Predictors of osimertinib response at second-line treatment in EGFR mutant non-small cell lung cancer patients with acquired T790M resistance mutation

Annals of Oncology ◽

10.1016/j.annonc.2021.08.2015 ◽

2021 ◽

Vol 32 ◽

pp. S1351

Author(s):

I. Dogan ◽

M. Gürbüz ◽

N. Paksoy ◽

N. Khanmamadov ◽

S. Vatansever ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Resistance Mutation ◽

Small Cell ◽

Line Treatment ◽

Second Line ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Mutant

Download Full-text

Erratum to: Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: Results of a Phase II trial

Investigational New Drugs ◽

10.1007/s10637-013-9996-x ◽

2013 ◽

Vol 31 (6) ◽

pp. 1628-1628

Author(s):

Craig Reynolds ◽

Alexander I. Spira ◽

Larry Gluck ◽

Suzanne J. Bradie-Muller ◽

Feng Zhan ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Sunitinib Malate ◽

Lung Cancer Patients

Download Full-text

Combination of apatinib and docetaxel in treating advanced non-squamous non-small cell lung cancer patients with wild-type EGFR: a multi-center, phase II trial

Journal of Thoracic Disease ◽

10.21037/jtd.2020.03.54 ◽

2020 ◽

Vol 12 (5) ◽

pp. 2450-2458

Author(s):

Yong Song ◽

Liyun Miao ◽

Zhaoxia Wang ◽

Meiqi Shi

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Wild Type ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Nivolumab for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia: A multicenter, open-label single-arm phase II trial

Lung Cancer ◽

10.1016/j.lungcan.2019.06.001 ◽

2019 ◽

Vol 134 ◽

pp. 274-278 ◽

Cited By ~ 17

Author(s):

Daichi Fujimoto ◽

Makiko Yomota ◽

Akimasa Sekine ◽

Mitsunori Morita ◽

Takeshi Morimoto ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Interstitial Pneumonia ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Open Label ◽

Lung Cancer Patients

Download Full-text

Phase II trial of prolonged infusion gemcitabine as second line treatment in non-small cell lung cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7316 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7316-7316

Author(s):

M. B. Kleinman ◽

I. Stewart ◽

S. Ratmanskiy ◽

M. Gayle ◽

P. Bonomi

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Second Line ◽

Small Cell Lung ◽

Prolonged Infusion

Download Full-text

A multicenter phase II trial with gemcitabine plus oxaliplatin as second line treatment in patients with advanced non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7263 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7263-7263

Author(s):

C. Kouroussis ◽

K. Syrigos ◽

A. Potamianou ◽

N. Ziras ◽

P. Ziotopoulos ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Second Line ◽

Small Cell Lung ◽

Multicenter Phase

Download Full-text

Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions

Respiratory Medicine ◽

10.1016/s0954-6111(98)90294-3 ◽

1998 ◽

Vol 92 (3) ◽

pp. 473-479 ◽

Cited By ~ 21

Author(s):

R.-P. Perng ◽

Y.-M. Chen ◽

M.-F. Wu ◽

K.-C. Chou ◽

W.-C. Lin ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Pleural Effusions ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text